159 related articles for article (PubMed ID: 6620573)
1. [Cellular changes in malignant pleural effusion induced by intrapleural injection of BCG-CWS].
Matsuda M; Morishita T; Horai T; Ikegami H; Nakamura S; Nishio H
Gan No Rinsho; 1983 Aug; 29(9):955-61. PubMed ID: 6620573
[TBL] [Abstract][Full Text] [Related]
2. [Local application of anti-cancer drugs for the treatment of malignant pleural and pericardial effusion].
Fukuoka M; Takada M; Tamai S; Negoro S; Matsui K; Ryu S; Sakai N; Sakaguchi K
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1543-9. PubMed ID: 6206796
[TBL] [Abstract][Full Text] [Related]
3. Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin.
Yasumoto K; Manabe H; Yanagawa E; Nagano N; Ueda H; Hirota N; Ohta M; Nomoto K; Azuma I; Yamamura Y
Cancer Res; 1979 Aug; 39(8):3262-7. PubMed ID: 222448
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of the patients with malignant pleural effusion with BCG cell-wall skeleton.
Yamamura Y; Ogura T; Yoshimoto T; Nishikawa H; Sakatani M
Gan; 1976 Oct; 67(5):669-77. PubMed ID: 797625
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients].
Shimizu T; Takahashi N; Terakado M; Sato M; Sugane T; Kisohara A; Akusawa H; Tsujino I; Horie T
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1139-43. PubMed ID: 16121916
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic experience in lung cancer using BCG cell-wall skeleton--with special reference to cases of pleural effusion].
Morishita M
Kekkaku; 1977 Oct; 52(10):531-2. PubMed ID: 599772
[No Abstract] [Full Text] [Related]
7. [Immunotherapy of resectable lung cancer using Nocardia rubra cell wall skeleton].
Ogura T
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):366-72. PubMed ID: 6349535
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS).
Yamamura Y; Sakatani M; Ogura T; Azuma I
Cancer; 1979 Apr; 43(4):1314-9. PubMed ID: 221088
[TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha in serum and carcinomatous pleural effusion after repeated intrapleural injections of antitumor agents.
Kaneto E; Sasaki H; Tamura I; Kurimura O; Kurimura T
Biken J; 1983 Jun; 26(2):99-102. PubMed ID: 6318725
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of pleural effusion caused by lung carcinoma with circular intrapleural hyperthermic perfusion and its mechanism].
Kang M; Zhou L; Lin P
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1176-9. PubMed ID: 11769704
[TBL] [Abstract][Full Text] [Related]
11. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of intrapleural treatment with aclacinomycin combined with closed tube thoracostomy for malignant pleural effusion].
Fujii M; Okabe K; Toki H; Fujita Y; Ishimitsu T
Gan No Rinsho; 1984 Jul; 30(8):895-8. PubMed ID: 6471394
[TBL] [Abstract][Full Text] [Related]
13. [Intralymphatic administration of BCG-CWS in advanced malignant melanoma].
Mannami T; Matsumi A; Ichikawa J; Kagawa S; Orita K; Motoi M
Gan To Kagaku Ryoho; 1982 Jan; 9(1):85-90. PubMed ID: 7184364
[TBL] [Abstract][Full Text] [Related]
14. Induction of lymphokine-activated killer cells by intrapleural instillations of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer.
Yasumoto K; Mivazaki K; Nagashima A; Ishida T; Kuda T; Yano T; Sugimachi K; Nomoto K
Cancer Res; 1987 Apr; 47(8):2184-7. PubMed ID: 3493843
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetics and pleural reaction of doxycycline after intrapleural administration].
Homma T; Yoneda S; Komuro Y; Yoshida S; Min KY; Takayama S
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1129-34. PubMed ID: 6870294
[TBL] [Abstract][Full Text] [Related]
16. [Aclacinomycin; benefits for the treatment of malignant pleural effusion].
Homma T; Min KY; Yoneda S; Yoshida S; Nakagawa H
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1810-6. PubMed ID: 6309098
[TBL] [Abstract][Full Text] [Related]
17. [Immunotherapy with BCG-CWS (cell-wall skeleton) in patients with primary lung cancer (author's transl)].
Takano T; Morishita M; Yamamoto M; Yamagata K; Takada K
Nihon Kyobu Shikkan Gakkai Zasshi; 1977 Nov; 15(11):769-74. PubMed ID: 606901
[No Abstract] [Full Text] [Related]
18. Intrapleural perfusion hyperthermo-chemotherapy for malignant pleural dissemination and effusion.
Matsuzaki Y; Shibata K; Yoshioka M; Inoue M; Sekiya R; Onitsuka T; Iwamoto I; Koga Y
Ann Thorac Surg; 1995 Jan; 59(1):127-31. PubMed ID: 7818311
[TBL] [Abstract][Full Text] [Related]
19. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
[TBL] [Abstract][Full Text] [Related]
20. Effector mechanism in concomitant immunity potentiated by intratumoral injection of Nocardia rubra cell wall skeleton.
Ogura T; Hara H; Yokota S; Hosoe S; Kawase I; Kishimoto S; Yamamura Y
Cancer Res; 1985 Dec; 45(12 Pt 1):6371-5. PubMed ID: 4063987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
